Joint U.S.-India Study of Lactobacillus and its Phages in Bacterial Vaginosis
Joint U.S.-India Study of Lactobacillus and its Phages in Bacterial Vaginosis
批准号:
7231218
负责人:
ARTHUR L REINGOLD
金额:
$7.32万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2009-08-31
关键词:
AddressAgeAreaAttentionBacteriaBacterial VaginosisBacteriophage TypingBacteriophagesBehaviorBirthCharacteristicsChildChildhoodClinicCohort StudiesCollaborationsCommunitiesConditionCross-Sectional StudiesCytolysisDataDevelopmentEndometritisEnrollmentEpidemiologic StudiesEpidemiologyEtiologyFetal Growth RetardationFollow-Up StudiesFoundationsGenomicsGoalsHerpes Simplex InfectionsHigh PrevalenceHormonal ChangeHuman Herpesvirus 2Hydrogen PeroxideIndiaInfantInfectionInfection of amniotic sac and membranesInterventionJointsLactobacillusLow Birth Weight InfantLyticMaternal MortalityMaternal and Child HealthMediatingMenstrual cycleMorbidity - disease rateMothersNeonatalOutcomeParticipantPlayPopulationPostpartum PeriodPremature LaborPremature Rupture Fetal MembranesPublic HealthRangeRateRelative (related person)ResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsRoleSexually Transmitted DiseasesSpermatocidal AgentsStagingSubgroupTestingTimeTrainingVaginaVaginal DouchingVirusWomancare seekingcohortcostmicroorganismmortalityneonateprospectivereproductivevaginal fluidvaginal lactobacilli
中文摘要
描述(由申请人提供):拟议的研究将调查细菌性阴道病的危险因素,并描述来自印度迈索尔育龄妇女的乳杆菌菌株和乳杆菌噬菌体的特征。利用已有的一项纳入750名育龄妇女的单纯疱疹2型感染前瞻性队列研究,我们将在一项探索性横断面研究中招募200名妇女,以调查印度迈索尔育龄妇女细菌性阴道病的危险因素,并在该人群中识别和表征乳杆菌和乳杆菌噬菌体。此外,我们将对20名妇女进行为期三个月的可行性亚研究,以确定我们是否可以直接从阴道菌群中等的妇女中分离噬菌体,并确定噬菌体类型分布是否随时间而变化。这是印度首次进行此类研究,将为验证噬菌体可能导致细菌性阴道病的假设奠定基础。本研究的目的是:1)收集印度迈索尔育龄妇女细菌性阴道病的危险因素和相关因素的信息;2)鉴定在印度迈索尔育龄妇女的阴道液中发现的乳杆菌种类;3)分析印度迈索尔育龄妇女阴道分泌液中阴道乳杆菌分离噬菌体的分布和类型;4)调查在阴道菌群中等的一小群妇女的阴道液中发现的噬菌体类型随时间的相对变化。拟议的研究以下列方式实现妇幼保健战略的目标:1)促进孕产妇和儿童健康方面的合作,并有助于全球了解孕产妇和儿童发病和死亡的原因。这项研究将促进向印度研究人员转让技术能力和培训;在细菌性阴道病具有高度公共卫生重要性的环境中建设基础设施,因为它会导致新生儿的死亡率和发病率;将急需的注意力集中在过去很少受到关注的情况上;并为印度和美国的研究人员更好地了解细菌性阴道病的流行病学、文化特异性风险因素和噬菌体在病因学中的作用提供机会;2)解决孕产妇、新生儿和儿科发病率和死亡率的主要原因;3)它侧重于MCHDR的“高优先级”领域:调查“不良出生结果的风险因素,包括低出生体重和宫内生长迟缓”。
英文摘要
DESCRIPTION (provided by applicant): The proposed study will investigate risk factors for bacterial vaginosis in and characterize Lactobacillus strains and Lactobacillus phages from women of reproductive age in Mysore India. Taking advantage of an existing prospective cohort study of Herpes Simplex 2 infection that has enrolled 750 women of reproductive age, we will enroll 200 women in an exploratory cross-sectional study to investigate the risk factors for bacterial vaginosis among reproductive age women in Mysore, India, and identify and characterize Lactobacillus and Lactobacillus phages among this population. In addition we will carry out a feasibility sub- study following 20 women bimonthly for three months to determine if we can isolate phages directly from women with intermediate vaginal flora, and determine if phage type distribution changes over time in vaginal fluids. This study, the first of its kind ever to be conducted in India, will lay the foundation to test the hypothesis that bacteriophage might be responsible for causing bacterial vaginosis. The aims of the study are to: 1) Collect information about risk factors and correlates of bacterial vaginosis among a population of reproductive-age women in Mysore, India; 2) Identify the Lactobacillus species found in vaginal fluids of a population of reproductive-age women in Mysore, India; 3) Analyze the distribution and types of phages isolated from vaginal Lactobacillus found in vaginal fluids of a population of reproductive-age women in Mysore, India; 4) Investigate the relative change, over time, in phage types found in the vaginal fluids of a small subgroup of women identified as having intermediate vaginal flora. The proposed research addresses the goals of MCHDR in the following ways: 1) It facilitates collaboration on maternal and children's health and contributes to a global understanding of the causes of morbidity and mortality in mothers and children. The research will facilitate the transfer of technical capacity and training to Indian researchers; build infrastructure in a setting where bacterial vaginosis has high public health importance because of its contribution to mortality and morbidity among neonates; focus much needed attention on a condition that has received minimal attention in the past; and provide an opportunity for both Indian and U.S. investigators to better understand the epidemiology, culturally specific risk factors, and role of phages in the etiology of bacterial vaginosis; 2) It addresses a leading cause of maternal, neonatal, and pediatric morbidity and mortality and India and; 3) It focuses on a "high priority" area for MCHDR: investigating "the risk factors for adverse birth outcomes including low birth weight and intrauterine growth retardation".
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV Implementation Science Research Training Program
-
批准号:8509546
-
项目类别:
-
资助金额:$27.28万
-
财政年份:2013
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8204681
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:7796852
-
项目类别:
-
资助金额:$21.64万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8638660
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:7679337
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8976788
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8775695
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:8400387
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:9187498
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
Berkeley Minority Health/Global Health (MH/GH) Training Program
-
批准号:7994847
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2009
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7036490
-
项目类别:
-
资助金额:$211.84万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:8205092
-
项目类别:
-
资助金额:$204.24万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7168223
-
项目类别:
-
资助金额:$289.84万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7548133
-
项目类别:
-
资助金额:$385.48万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7992826
-
项目类别:
-
资助金额:$298.82万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:7345435
-
项目类别:
-
资助金额:$297.88万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program-ARRA-HAI
-
批准号:7895261
-
项目类别:
-
资助金额:$45.84万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program
-
批准号:6967230
-
项目类别:
-
资助金额:$285.52万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program-ARRA 317 Supplement
-
批准号:8066520
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
California Emerging Infections Program-ARRA-317
-
批准号:7908340
-
项目类别:
-
资助金额:$59.07万
-
财政年份:2004
-
负责人:ARTHUR L REINGOLD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: